The Coe is established to integrate research and education on different aspects of molecular medicine (angiogenesis, mechanisms of drug hypersensivity, genetic aspects of cancer development, diseases resulting from defected protein folding (prisons), apoptosis of cancer cells in haematological malignancies, dendric cells in SM of pituitary gland tumours). The long-term aim is to develop new therapies to fight civilisation diseases. Main priority will be to attract young researchers and intensify the exchange programme involving experts from leading EU institutes. The Coe will provide a consulting activity and undertake measures to improve social image of science. New fields of research such as polemics of endothelial and nervous cells, pharmacoproteomics and genomic research will be developed.